[1]
Ahmed, S. et al. 2025. Comparison of Efficacy and Safety of Vildagliptin and Linagliptin in Patients of Type 2 Diabetes Mellitus with Chronic Kidney Disease. Community Based Medical Journal. 14, 1 (Jan. 2025), 96–100. DOI:https://doi.org/10.3329/cbmj.v14i1.79340.